Wendy Vetter, DO
Internal Medicine · Sioux Falls, SDNPI 1053575092
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 97.4% of the total across 350 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 40 manufacturers, the largest accounting for just 10.8% — the pattern of someone who eats at a lot of different presentations. Among internal medicine clinicians in SD with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 350 payments — averaging $13.91 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Amgen$528
- AbbVie$528
- Lilly USA, LLC$486
- Novo Nordisk$422
- Pfizer$389
- Merck$362
- plus $2K from 34 others
What the payments were for
- Food & beverage$4,74497%
- Education$1253%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Amgen | 38 | $528 |
| AbbVie(2 entities) | 39 | $528 |
| Lilly USA, LLC | 35 | $486 |
| Novo Nordisk | 28 | $422 |
| Pfizer | 45 | $389 |
| Merck | 32 | $362 |
| AstraZeneca | 11 | $302 |
| Astellas Pharma US Inc | 9 | $193 |
| Johnson & Johnson | 10 | $153 |
| Daiichi Sankyo Inc. | 9 | $145 |
| Sunovion Pharmaceuticals Inc. | 14 | $130 |
| Boehringer Ingelheim | 7 | $123 |
| Sanofi-aventis U.S. LLC | 7 | $104 |
| Amarin Pharma, Inc. | 6 | $103 |
| Teva Pharmaceuticals USA, Inc. | 7 | $99 |
| Phathom Pharmaceuticals, Inc. | 6 | $80 |
| GSK | 5 | $68 |
| Mylan Specialty L.p. | 4 | $65 |
| Takeda Pharmaceuticals U.S.A., Inc. | 6 | $51 |
| E.r. Squibb & Sons, L.L.C. | 3 | $45 |
| Grifols USA, LLC | 2 | $43 |
| Idorsia Pharmaceuticals US Inc | 3 | $41 |
| Insmed, Inc. | 2 | $34 |
| Bayer | 2 | $33 |
| Abbott | 2 | $31 |
| Eisai Inc. | 2 | $30 |
| Actelion Pharmaceuticals US, Inc. | 2 | $29 |
| Viatris Specialty LLC | 1 | $28 |
| Biohaven Pharmaceutical Holding Company Ltd. | 2 | $27 |
| Corcept Therapeutics | 1 | $24 |
| Boston Scientific | 1 | $23 |
| Sanofi Pasteur Inc. | 1 | $19 |
| Novartis | 1 | $19 |
| Medtronic | 1 | $18 |
| Inspire Medical Systems, Inc. | 1 | $17 |
| Biohaven Pharmaceuticals, Inc. | 1 | $17 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 1 | $16 |
| Impel Pharmaceuticals Inc. | 1 | $15 |
| Almatica Pharma LLC | 1 | $15 |
| Dexcom, Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- FARXIGA$112
- SYMBICORT$112
- BEVESPI AEROSPHERE$112
How this compares
$4,869 in reported general payments places this provider in the 95th percentile of 178 internal medicine providers in South Dakota.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| JardianceEmpagliflozin | 40 | $49,890 |
| EliquisApixaban | 51 | $42,800 |
| OzempicSemaglutide | 31 | $30,181 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 42 | $29,931 |
| LinzessLinaclotide | 22 | $21,144 |
| XareltoRivaroxaban | 20 | $18,344 |
| FarxigaDapagliflozin Propanediol | 16 | $15,234 |
| MounjaroTirzepatide | 11 | $11,804 |
| BelsomraSuvorexant | 16 | $10,218 |
| Xigduo XrDapaglifloz Propaned/Metformin | 14 | $9,306 |
| Anoro ElliptaUmeclidinium Brm/Vilanterol Tr | 18 | $9,165 |
| Repatha SureclickEvolocumab | 14 | $7,746 |
| ZonisadeZonisamide | 15 | $5,800 |
| Estradiol | 55 | $3,907 |
| Levothyroxine Sodium | 431 | $3,889 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Boehringer IngelheimJardiance | $123 | $49,89040 claims |
| PfizerEliquis | $389 | $42,80051 claims |
| GSKTrelegy Ellipta, Anoro Ellipta | $68 | $39,09660 claims |
| Novo NordiskOzempic | $422 | $30,18131 claims |
| AbbVieLinzess, Synthroid | $528 | $24,53368 claims |
| Johnson & JohnsonXarelto | $153 | $18,34420 claims |
| AstraZenecaFarxiga | $302 | $15,23416 claims |
| Lilly USA, LLCMounjaro | $486 | $11,80411 claims |
| MerckBelsomra | $362 | $10,21816 claims |
| Almatica Pharma LLCSertraline Hcl | $15 | $1,400150 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 178 internal medicine providers in South Dakota.
Other internal medicine in Sioux Falls
- Janell PowellSioux Falls$7K
- Maaz BadshahSioux Falls$6K
- Jeffrey HeierSioux Falls$4K
- Shristi Upadhyay BanskotaSioux Falls$3K
- Anup ShresthaSioux Falls$1K
- Whitnee OttoSioux Falls$1K
- Alla ZamulkoSioux Falls$969
- Chirag PatelSioux Falls$924
- Brooke MadsonSioux Falls$760
- Syed Asif ShahSioux Falls$735
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.